Darlington nuclear to become new source of lifesaving medical isotopes

A collaboration between Ontario Power Generation’s (OPG) subsidiary Canadian Nuclear Partners (CNP) and a subsidiary of BWX Technologies, Inc. (BWXT) will make Darlington Nuclear the first large scale commercial nuclear power station worldwide to produce molybdenum-99 (Mo-99). This will help ensure the world’s long term supply of this critical medical isotope, which is used in over 30 million lifesaving diagnostic and medical treatments each year.